Inventor · disambiguated record
Nathaniel J. Washburn
Also filed as: WASHBURN NATHANIEL · WASHBURN NATHANIEL J
12 granted patents·20 pending applications·65 citations·filing 2008–2023
89Inventor score
Files withMOMENTA PHARMACEUTICALS INC28BOSQUES CARLOS1BULIK DOROTA A1MOMENTA PHARMACEUTCALS INC1WASHBURN NATHANIEL J1
Top patents by PatentIndex Score
32 records- 0192US11155640B2Compositions and methods related to engineered Fc constructsMOMENTA PHARMACEUTICALS INC·Filed 2017·Granted Oct 26, 2021·6 cites·2 claims
- 0289US9890410B2N-acetylhexosamine-containing N-glycans in glycoprotein productsMOMENTA PHARMACEUTICALS INC·Filed 2015·Granted Feb 13, 2018·7 cites·34 claims
- 0387US11345751B2FcRn antibodies and methods of use thereofMOMENTA PHARMACEUTICALS INC·Filed 2017·Granted May 31, 2022·4 cites·40 claims
- 0487US8586356B2Gal α1-3gal-containing N-glycans in glycoprotein products derived from CHO cellsBOSQUES CARLOS·Filed 2009·Granted Nov 19, 2013·15 cites·18 claims
- 0585US9663581B2Modified glycoproteinsMOMENTA PHARMACEUTICALS INC·Filed 2013·Granted May 30, 2017·7 cites·15 claims
- 0685US2024141401A1Sialylated GlycoproteinsMOMENTA PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0785US2024167069A1Sialylated GlycoproteinsMOMENTA PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0884US2024279703A1Sialylated GlycoproteinsMOMENTA PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0983US9170249B2N-acetylhexosamine-containing N-glycans in glycoprotein productsWASHBURN NATHANIEL J·Filed 2012·Granted Oct 27, 2015·10 cites·26 claims
- 1083US8043863B2MS methods to evaluate glycansMOMENTA PHARMACEUTICALS INC·Filed 2008·Granted Oct 25, 2011·14 cites·20 claims
- 1174US12297291B2Compositions and methods related to engineered Fc constructsMOMENTA PHARMACEUTICALS INC·Filed 2021·Granted May 13, 2025·0 cites·3 claims
- 1273US2021040527A1Sialylated GlycoproteinsMOMENTA PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1373US2021277438A1Sialylated GlycoproteinsMOMENTA PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1472US2021017563A1Sialylated GlycoproteinsMOMENTA PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1570US2020032312A1Sialylated glycoproteinsMOMENTA PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 1665US2018305725A1Sialylated GlycoproteinsMOMENTA PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 1764US9650433B2Modified glycoproteinsBULIK DOROTA A·Filed 2012·Granted May 16, 2017·1 cites·14 claims
- 1864US2023049725A1FcRn Antibodies and Methods of Use ThereofMOMENTA PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1963US10023894B2Galactose-alpha-1, 3-galactose-containing n-glycans in glycoprotein products derived from CHO cellsMOMENTA PHARMACEUTICALS INC·Filed 2015·Granted Jul 17, 2018·1 cites·17 claims
- 2060US2020109432A1Analysis of Disulfide BondsMOMENTA PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 2160US2016108450A1Sialylated glycoproteinsMOMENTA PHARMACEUTCALS INC·Filed 2014·Application pending·0 cites
- 2257US10377809B2Modified glycoproteinsMOMENTA PHARMACEUTICALS INC·Filed 2017·Granted Aug 13, 2019·0 cites·13 claims
- 2355US2018305440A1Glycoproteins with anti-inflammatory propertiesMOMENTA PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 2455US2015210753A1Glycoproteins with anti-inflammatory propertiesMOMENTA PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 2555US2023357813A1Hypersialylated immunoglobulinMOMENTA PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 2653US10377832B2Modified glycoproteinsMOMENTA PHARMACEUTICALS INC·Filed 2017·Granted Aug 13, 2019·0 cites·15 claims
- 2753US2023417762A1Sialylated glycoproteinsMOMENTA PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 2850US2014045212A1Gal alpha 1-3gal-containing n-glycans in glycoprotein products derived from cho cellsMOMENTA PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 2943US2015275266A1Analysis of disulfide bondsMOMENTA PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 3043US2015252108A1Glycoprotein preparationsMOMENTA PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 3141US2019048417A1Therapeutic and Diagnostic Methods for Autoimmune Diseases and/or InflammationMOMENTA PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 3239US2011136682A1Antennary fucosylation in glycoproteins from cho cellsMOMENTA PHARMACEUTICALS INC·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Nathaniel J. Washburn files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →